How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Succinate Dehydrogenase Inhibitor (SDHI) Market
- By Application Crop Type: Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses, Turf & Ornamentals, Other Commercial Crops
- By Formulation Type: Wettable Powder (WP), Suspension Concentrate (SC), Granules (GR), Emulsifiable Concentrate (EC), Water Dispersible Granules (WDG)
- By Mode of Application: Foliar Spray, Seed Treatment, Soil Treatment
- By Target Fungal Diseases: Powdery Mildew, Leaf Spot, Rust, Blight, Anthracnose
- By End-User: Agricultural Farmers, Commercial Growers, Turf Management Professionals, Greenhouse Operators
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Cereals & Grains leads By Application Crop Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Succinate Dehydrogenase Inhibitor (SDHI) Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Application Crop Type 5
Formulation Type 5
Mode of Application 3
Target Fungal Diseases 5
End-User 4
Companies profiled
BASF SE
Syngenta AG
Bayer Crop Science
FMC Corporation
ADAMA Agricultural Solutions Ltd.
Nufarm Limited
UPL Limited
Sumitomo Chemical Co. Ltd.
Corteva Agriscience
Mitsui Chemicals Inc.
Nippon Soda Co. Ltd.
Isagro S.p.A.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bayer Crop Science
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →FMC Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →ADAMA Agricultural Solutions Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nufarm Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →UPL Limited
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Sumitomo Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Corteva Agriscience
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Mitsui Chemicals Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Nippon Soda Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Isagro S.p.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Nissan Chemical Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Arysta LifeScience Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Valent U.S.A. LLC
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,509M by 2033 · 9.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Cereals & Grains42.9
- Fruits & Vegetables13.9
- Oilseeds & Pulses10.6
- Turf & Ornamentals13.6
- Other Commercial Crops19.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$857.3M → $1,860M · 10.2%
Europe$597.5M → $1,225M · 9.4%
Asia Pacific$545.5M → $1,164M · 9.9%
Latin America$337.7M → $672.5M · 9.0%
Middle East and Africa$259.8M → $492.3M · 8.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.802026
9.822027
9.832028
9.832029
9.862030
9.872031
9.882032
9.892033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE12.7
- Syngenta AG25.5
- Bayer Crop Science8.0
- FMC Corporation9.7
- ADAMA Agricultural Solutions Ltd.9.4
- Nufarm Limited6.6
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Application Crop Type18.0%
Formulation Type21.3%
Mode of Application29.0%
Target Fungal Diseases12.8%
End-User18.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.4
- Europe22.6
- Asia Pacific21.5
- Latin America12.4
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 89 | 85 | 81 | 87 | 91 | 87 | 87 |
| Syngenta AG | 76 | 68 | 78 | 92 | 73 | 76 | 77 |
| Bayer Crop Science | 78 | 84 | 80 | 72 | 85 | 82 | 80 |
| FMC Corporation | 81 | 76 | 68 | 60 | 82 | 59 | 71 |
| ADAMA Agricultural Solutions Ltd. | 64 | 55 | 68 | 52 | 71 | 55 | 61 |
| Nufarm Limited | 53 | 49 | 67 | 46 | 54 | 51 | 53 |
| UPL Limited | 66 | 53 | 46 | 59 | 55 | 48 | 55 |
| Sumitomo Chemical Co. Ltd. | 50 | 52 | 47 | 40 | 50 | 53 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Syngenta AG
- Bayer Crop Science
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Syngenta AG | ✓ | ◐ | ◐ | ✓ | ◐ | ✓ |
| Bayer Crop Science | ✓ | ✓ | ✓ | ◐ | ◐ | ◐ |
| FMC Corporation | ✓ | ✓ | ◐ | − | ✓ | − |
| ADAMA Agricultural Solutions Ltd. | ◐ | − | ◐ | − | ◐ | ◐ |
| Nufarm Limited | ◐ | ◐ | ◐ | − | ◐ | − |
| UPL Limited | ◐ | ◐ | − | ◐ | − | ◐ |
| Sumitomo Chemical Co. Ltd. | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE87
2Bayer Crop Science80
3Syngenta AG77
4FMC Corporation71
5ADAMA Agricultural Solutions Ltd.61
6UPL Limited55
7Nufarm Limited53
8Sumitomo Chemical Co. Ltd.49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BASF SEBayer Crop Science
Challenger2
Strong scale, closing on the leaders.
Syngenta AGFMC Corporation
Contender1
Focused players with pockets of strength.
ADAMA Agricultural Solutions Ltd.
Niche3
Specialists in a single segment or region.
Nufarm LimitedUPL LimitedSumitomo Chemical Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application Crop Type in North America, then scale across Succinate Dehydrogenase Inhibitor (SDHI) Market — a $939M beachhead inside a $12.8B market.
Beachhead (SOM)$939Mobtainable near-term
Serviceable (SAM)$5.13Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Cereals & Grains
Best fit — highest urgency & budget in Application Crop Type.
Economic buyer78 fit
Fruits & Vegetables
Strong fit — clear ROI and a fast path to value.
End user69 fit
Oilseeds & Pulses
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application Crop Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Formulation Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Mode of Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Application Crop Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Succinate Dehydrogenase Inhibitor (SDHI) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified23%
Evaluation14%
Closed-won6%
$12.0KCAC
$42KLTV
3.5:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Succinate Dehydrogenase Inhibitor (SDHI) Market is a resilient opportunity — $7.22B by 2033, compounding at 4.5%.
TAM · 2025$5.09Btoday
TAM · 2033$7.22Bforecast
CAGR4.5%2027–2033
Cumulative$54.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.22BTotal addressable market
SAM$2.54BServiceable available market
SOM$410MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.5% CAGR
Demand compounds through 2033, outpacing GDP across Application Crop Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application Crop Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.22BLarge & growingTAM by 2033 at 4.5% CAGR
$2.54BServiceable nowreachable with today’s model
$410MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.63BBear2.9% CAGR
$7.22BBase4.5% CAGR
$9.24BBull5.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Formulation Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Succinate Dehydrogenase Inhibitor (SDHI) Market — a $6.31B market by 2033. Plan: grow share from 8.8% to 14.4%.
Market size · 2033$6.31Btotal addressable
Market CAGR11.4%2027–2033
Target share14.4%from 8.8% today
Revenue ambition$909Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.8% | 14.4% | Behind |
| Revenue | $563M | $909M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 34.1% | 38.9% | On track |
| Customer retention | 87.1% | 93.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application Crop Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Formulation Type capability
A defensible second engine — invest in Formulation Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application Crop Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Formulation Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $112M capacity & capability investment
- Greenlight bolt-on M&A in Formulation Type
- Authorise North America expansion plan
- Fund R&D program for Application Crop Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Succinate Dehydrogenase Inhibitor (SDHI) Market conversation — a $9.37B market you can size, segment and defend in minutes.
Market size · 2033$9.37Btotal opportunity
Growth10.0%CAGR to 2033
Addressable buyers1,587+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application Crop Type
Goal Grow share in Application Crop Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$66K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
BASF SESyngenta AGBayer Crop ScienceFMC CorporationADAMA Agricultural Solutions Ltd.Nufarm LimitedUPL LimitedSumitomo Chemical Co. Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Succinate Dehydrogenase Inhibitor (SDHI) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Succinate Dehydrogenase Inhibitor (SDHI) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Subtype HEK293 Medium Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportSubstance Use Disorder Treatment Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportSubstance P Market
Market size, share, segmentation and regional forecast.
$842M market · 2025 base year
View reportSubstance Abuse Testing Services Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportSubstance Abuse Screening Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportSubstance Abuse and Addiction Treatment Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportSubperiosteal Dental Implants Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportSuboxone and Methadone Treatment Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportSubmucosal Tissue Lifting Agent Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportSubmucosal Lifting Injection Solution Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportSubmucosal Lifting Agent Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportSubmucosal Injection Solution Market
Market size, share, segmentation and regional forecast.
$806M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.